Achillion Today
News
Visit the Achillion News Center for the Companys latest press releases, upcoming events and media resources.
more
NEW
EASL 2010 Poster Presentations:
Clinical Efficacy, Safety, and Pharmacokinetic Profile
download
Demonstration of ACH-1625s Hepatoselective Distribution
download
Virologic Profile of ACH-1625
download
Achillion video from Hartford Business Journal
Achillion's 'Very Promising' New Drug for Hepatitis C
Investor Information
Achillion strives to keep its investors as up-to-date as possible. This section facilitates investor access to current and historical share price, analyst coverage, SEC filings, an electronic version of Achillions annual report and frequently asked questions as well as forms to request additional information.
more
Featured Employee
On a quarterly basis, Achillion highlights one employee who has made significant contributions to the advancement of the Company's mission.
more
Business Development
Achillion intends to establish strategic collaborations where it believes it can accelerate the development or maximize the value of its drug candidates by utilizing the financial, clinical development, manufacturing and /or commercialization strengths of a leading biotechnology or pharmaceutical company.
more
Home
|
About Us
|
Target Markets
|
Product Pipeline
|
News Center
|
Investors
|
Contact Us
|
Site Map
© Copyright 2007 Achillion Pharmaceuticals, Inc. All rights reserved.
Terms of Use & Privacy Policy
Last Updated (
August 01, 2007
)